Mental Health Treatments Top List of US Healthcare Spending
According to new research, the United States spends over 200 billion annually on treatment and hospitalization for mental health issues, exceeding spending on heart...
Antidepressants Not a ‘One Size Fits All’ Solution, Researchers Find
The largest ever study of the thoughts and reactions of antidepressant users reveals that many people have vastly different understandings and experiences of the...
Review Links Antipsychotics with Risk for Heart Attacks
A systematic review published this week in the British Journal of Clinical Pharmacology found that patients taking antipsychotic drugs were at nearly twice the risk...
“The Unfulfilled Promise of the Antidepressant Medications”
A new article in The Medical Journal of Australia laments that, while antidepressant use continues to climb, the research evidence shows that their effectiveness...
Childhood Trauma Predicts Lack of Response to Antidepressants
Research in Translational Psychiatry finds that childhood maltreatment and trauma predict a greater likelihood of developing chronic depression, and a reduced likelihood of responding to treatment...
Interview: Researchers Deconstruct Ghostwritten Industry Trial for Antidepressant
Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that was ghostwritten and then used by the manufacturers to support claims of the drug’s efficacy and safety in the treatment of child and adolescent depression. To get the background on this story, we connected with Dr. Leemon McHenry, an investigator in this study and a lecturer in philosophy at California State University, Northridge.
Antidepressants Do Not Prevent Suicides, May Increase Risk
When the CDC released data revealing an increasing suicide rate in the US, some experts, speaking to major media outlets, speculated that the increase...
Psych Patients Who Resist Stigma Do Better
A new study in press in the Journal of Schizophrenia Research finds that patients who actively resist the negative stigma associated with mental health...
Olanzapine Can Cause Serious Skin Reaction, FDA Warns
The US FDA has issued a new warning for the atypical antipsychotic Olanzapine, also known by the brand names Zyprexa and Symbyax. The agency...
“CDC Warns that Americans May be Overmedicating Youngest Children with ADHD”
The Centers for Disease Control and Prevention (CDC) released new data indicating that as many as 75% of young children who are diagnosed with...
FDA Warns About New Impulse-Control Problems Associated With Abilify
Yesterday, the US Food and Drug Administration (FDA) released a warning that the antipsychotic drug aripiprazole or Abilify is associated with compulsive and uncontrollable...
Mindfulness Therapy Can Prevent Depression Relapse, Review Finds
Mindfulness-based cognitive therapy (MBCT) may be more effective at reducing the risk of depressive relapse compared to current standard treatments with antidepressant drugs. A...
Group Mindfulness Shows Promise Reducing Depression Associated with Hearing Voices
A new study out of Kings College London found that twelve sessions of a group mindfulness-based therapy relieved distress associated with hearing voices while reducing depression over the long-term. The person-based cognitive therapy (PBCT) intervention had significant effects on depression, voice distress, voice controllability and overall recovery.
Lancet Editorial Points to “Trouble with Psychiatry Trials”
While clinical trials make up the “bedrock of evidence-based medicine” in other specialties, psychiatry faces a number of both ethical and scientific problems related to its use of randomized control trials. According to a new editorial in The Lancet Psychiatry, the field of psychiatry research has particular problems with ethical issues in recruitment, inaccurate classification systems, and controversial placebo comparisons, and then, once the studies are finished, it often remains unclear what the “outcomes actually mean for people’s lives.”
Mental Health Documentary “Healing Voices” Premiers Across 130 Communities in 8 Countries
The producers of “Healing Voices” ‐ a new social action documentary about mental health ‐ are releasing the film via community screening partners in...
Intensive Care Patients at High Risk for PTSD, Psychiatric Symptoms
People who survive life-threatening illnesses in the intensive care unit (ICU) of a hospital are at high risk for depression and anxiety and nearly...
Suicide Rates Rise While Antidepressant Use Climbs
Multiple media sources are reporting on new data from the CDC revealing a substantial increase in the suicide rate in the United States between 1999...
Highly Cited JAMA Psych Paper Retracted for “Pervasive Errors”
A study, comparing the effects of antidepressants combined with psychotherapy for severe depression to antidepressants alone, has been retracted and replaced by JAMA Psychiatry....
Anticholinergic Drugs, Including Antidepressants, Linked To Later Cognitive Problems
A new study, published in JAMA Neurology, found that older people who regularly took anticholinergic drugs, including certain cold medicines or antidepressants, had poorer...
Legal Journal Says Antidepressants Can Cause Violence and Suicide
Antidepressants have been reported to cause a state called “akathisia,” where people feel extremely agitated and restless and may become preoccupied with thoughts of...
WSJ Hosts Debate on Depression Screening
The U.S. Preventive Services Task Force (USPSTF) recently issued a controversial recommendation that all adolescent and adult patients undergo depression screening in primary care. The...
NIMH Info for Parents on “ADHD” Misleading, Researchers Say
A new analysis of the information that the National Institute of Mental Health (NIMH) publishes for parents about attention deficit hyperactivity disorder (ADHD) concludes that the children’s experiences and contexts are ignored and that medication is presented, misleadingly, as the only solution supported by research evidence.
SSRIs in Pregnancy Linked to Early Depression in Children
A new study finds that prenatal exposure to antidepressant drugs, known as selective serotonin reuptake inhibitors or SSRIs, is associated with higher rates of...
Amphetamines Have Long-Term Effects on Adolescent Brain, Study Finds
A new study published in the journal Neuroscience finds that rats given regular doses of amphetamines during adolescence have brain and behavioral changes in adulthood....
Epidemiologists Decry Major Problems in US Psychiatric Practice
In an exchange published in the Journal of Clinical Epidemiology, researchers take turns highlighting major problems in the way psychiatry is currently practiced in the United States. In response to an article by Vinay Prasad calling for an insistence on randomized control trials in “evidence-based” medicine, Jose de Leon, from the Mental Health Research Center at the University of Kentucky begins the back-and-forth by pointing out that this type of evidence has been detrimental to the field of mental health.
